Kazia Therapeutics Limited (KZIA)
NASDAQ: KZIA · Real-Time Price · USD
8.19
+0.19 (2.37%)
Sep 15, 2025, 4:00 PM EDT - Market closed
Kazia Therapeutics Market Cap
Kazia Therapeutics has a market cap or net worth of $9.16 million as of September 15, 2025. Its market cap has decreased by -29.62% in one year.
Market Cap
9.16M
Enterprise Value
7.00M
1-Year Change
-29.62%
Ranking
Category
Stock Price
$8.19
Market Cap Chart
Since September 1, 1999, Kazia Therapeutics's market cap has decreased from $141.44M to $9.16M, a decrease of -93.53%. That is a compound annual growth rate of -9.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 8.94M | 16.02% |
| Dec 31, 2024 | 7.71M | -33.47% |
| Dec 29, 2023 | 11.59M | 15.31% |
| Dec 30, 2022 | 10.05M | -90.96% |
| Dec 31, 2021 | 111.18M | 11.75% |
| Dec 31, 2020 | 99.49M | 217.65% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.50B |
| Johnson & Johnson | 429.77B |
| AbbVie | 388.98B |
| UnitedHealth Group | 322.92B |
| AstraZeneca | 247.84B |
| Novartis AG | 247.58B |
| Novo Nordisk | 241.70B |
| Abbott Laboratories | 233.47B |